IRIS
MONNO, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.033
AS - Asia 5.074
EU - Europa 4.351
SA - Sud America 1.505
Continente sconosciuto - Info sul continente non disponibili 581
AF - Africa 308
OC - Oceania 3
AN - Antartide 1
Totale 25.856
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.847
SG - Singapore 1.957
IT - Italia 1.387
BR - Brasile 1.188
CN - Cina 1.044
HK - Hong Kong 876
DE - Germania 632
SE - Svezia 496
RU - Federazione Russa 396
UA - Ucraina 347
VN - Vietnam 336
FI - Finlandia 320
FR - Francia 259
GB - Regno Unito 237
IN - India 178
BD - Bangladesh 149
CI - Costa d'Avorio 133
AR - Argentina 103
ID - Indonesia 90
CA - Canada 77
IQ - Iraq 67
ZA - Sudafrica 56
EC - Ecuador 54
BE - Belgio 52
MX - Messico 51
CO - Colombia 48
IE - Irlanda 47
TR - Turchia 47
PK - Pakistan 43
VE - Venezuela 43
SA - Arabia Saudita 42
JP - Giappone 28
NL - Olanda 27
PL - Polonia 27
UZ - Uzbekistan 27
AT - Austria 24
KE - Kenya 24
PH - Filippine 24
MA - Marocco 21
MY - Malesia 20
CL - Cile 18
PY - Paraguay 17
TN - Tunisia 17
ES - Italia 16
JO - Giordania 16
IL - Israele 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
EG - Egitto 13
GR - Grecia 12
HR - Croazia 12
IR - Iran 12
AZ - Azerbaigian 11
PE - Perù 11
CR - Costa Rica 9
LT - Lituania 9
NP - Nepal 9
RS - Serbia 9
UY - Uruguay 9
BO - Bolivia 8
KZ - Kazakistan 8
TH - Thailandia 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
HN - Honduras 7
LB - Libano 7
OM - Oman 7
PS - Palestinian Territory 7
AL - Albania 6
GE - Georgia 6
PA - Panama 6
ET - Etiopia 5
JM - Giamaica 5
KW - Kuwait 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
HU - Ungheria 4
KR - Corea 4
PT - Portogallo 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
EU - Europa 3
GT - Guatemala 3
GY - Guiana 3
LY - Libia 3
SV - El Salvador 3
TW - Taiwan 3
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
BW - Botswana 2
CM - Camerun 2
GH - Ghana 2
KG - Kirghizistan 2
ME - Montenegro 2
MK - Macedonia 2
MN - Mongolia 2
Totale 25.244
Salva come PNG Salva come JPEG
Città #
Fairfield 1.822
Ashburn 1.292
Woodbridge 1.178
Singapore 1.033
Hong Kong 874
Chandler 806
Houston 792
Jacksonville 769
Seattle 717
San Jose 709
Wilmington 623
Cambridge 596
Milan 526
Ann Arbor 451
Nyköping 362
Council Bluffs 312
Beijing 298
Roxbury 226
Lawrence 223
Nanjing 205
New York 205
Lauterbourg 196
Rome 183
Princeton 141
Abidjan 133
Boardman 132
Des Moines 125
Los Angeles 123
Dallas 119
Helsinki 119
Santa Clara 107
São Paulo 106
Ho Chi Minh City 90
San Diego 81
Bari 77
Munich 73
Hanoi 69
Shenyang 66
Dong Ket 65
Inglewood 64
Brooklyn 54
Buffalo 54
Columbus 53
Nanchang 50
Hebei 49
Jakarta 49
London 48
Dublin 47
Rio de Janeiro 47
Figino 46
Chicago 36
Jiaxing 34
Tianjin 34
Turin 33
Brussels 31
Tokyo 27
Baghdad 26
The Dalles 26
Curitiba 25
Johannesburg 25
Nuremberg 24
Paris 24
Frankfurt am Main 23
Moscow 22
Tashkent 22
Taranto 21
Toronto 21
Warsaw 21
Belo Horizonte 20
Mexico City 20
Nairobi 20
San Francisco 20
Turku 20
Changsha 18
Mumbai 18
Naples 18
Quito 18
Atlanta 17
Brasília 17
Campinas 17
Lahore 17
Norwalk 17
Orem 17
Guayaquil 16
Medellín 16
Montreal 16
Pune 16
Riyadh 16
Denver 15
Dhaka 15
Falls Church 15
Florence 15
Jeddah 14
New Delhi 14
Phoenix 14
Caracas 13
Chennai 13
Kuala Lumpur 13
Porto Alegre 13
Washington 13
Totale 17.581
Salva come PNG Salva come JPEG
Nome #
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 389
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 370
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 226
Access to health services for undocumented immigrants in Apulia. 217
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 214
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 208
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 202
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 200
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 194
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 189
An outbreak of HIV-1 BC recombinants in Southern Italy 187
Aeromonas sobria sepsis complicated by rhabdomyolysis in an HIV-positive patient: case report and evaluation of traits associated with bacterial virulence 184
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 182
Potential diagnostic properties of chest ultrasound in thoracic tuberculosis—A systematic review 181
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 179
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 173
Aeromonas sobria sepsis complicated by rhabdomyolysis in an HIV-positive patient: case report and evaluation of traits associated with bacterial virulence 172
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 172
Amoebic hepatic abscesses in an HIV-positive patient 171
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 170
Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 169
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 167
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort. 166
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 166
The elderly and direct antiviral agents: Constraint or challenge? 165
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 161
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 160
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 160
Prevalence and Clinical Characteristics of Mycobacterial Diseases in the Barletta-Andria-Trani Province, Italy (2005-2013) 157
HIV tropism and its relationship with transmitted resistance in naive patients 157
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 157
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 156
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 154
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 154
Co-receptor switch during HAART is independent of virological success 153
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 153
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 150
Liver abscess due to Fusobacterium necrophorum in an immunocompetent patient 150
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 150
Access to Health Services for Undocumented Immigrants in Apulia 149
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 149
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review 147
Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique 147
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 147
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. 146
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 145
Infection caused by Sporothrix schenckii: an autochthonous case in Bari, Southern Italy 145
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 144
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 144
The at risk child clinic (ARCC): 3 years of health activities in support of the most vulnerable children in Beira, Mozambique 143
A multidrug-resistant (MDR) HIV type 1 infection in a homosexual man and identified source patient 140
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide 140
The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy. 139
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 139
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression 139
Focused ultrasound to diagnose HIV-associated tuberculosis (FASH) in the extremely resource-limited setting of South Sudan: a cross-sectional study 139
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 138
Are the proposed env mutations actually associated with resistance to maraviroc? 137
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 136
Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders. 135
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection 134
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA) 134
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 134
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV positive individuals before the start of antiretroviral therapy. 134
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 133
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 132
High HIV-1 diversity in immigrants resident in Italy (2008–2017) 132
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 130
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 130
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 130
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients. 130
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 130
Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy 129
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 129
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 128
Analisi della cinetica replicativa in cultura primaria di isolati di HIV-1 da soggetti in vario stadio di malattia 127
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 126
Tuberculosis and diabetes: Current state and future perspectives 125
Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique. 125
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review 125
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 124
HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users 124
Cell cultures from small amounts of heparinized whole blood enhance HIV-1 isolation rate 123
Association between HIV p24 antigen in cerebrospinal fluid and severe complications in the central nervous system 123
A rigorous statistical learning method for the estimation and validation of weighted drug susceptibility scores applied to in vivo virological outcome prediction of atazanavir/ritonavir containing HAART 122
Reversible reduction of nevirapine plasma concentrations during rifampicin treatment in patients coinfected with HIV-1 and tuberculosis 122
Pathways of care for HIV infected children in Beira, Mozambique: Pre-post intervention study to assess impact of task shifting 122
Effects of HIV superinfection on HBV replication in a chronic HbsAg carrier with liver disease 121
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors 120
Drug Resistance Mutations and Newly Recognized Treatment-Related Substitutions in the HIV-1 Protease Gene: Prevalence and Associations With Drug Exposure and Real or Virtual Phenotypic Resistance to Protease Inhibitors in Two Clinical Cohorts of Antiretroviral Experienced Patients 120
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 119
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort. 119
Uncommon testicular localization of Disseminated TB: a case report from Mozambique 119
Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals 118
Liver abscess due to Fusobacterium necrophorum in an immunocompetent patient. A case report and review of the literature 116
Intracellular and cell-free (infectious) HIV-1 in rectal mucosa 116
Association between HLA class II antigens and hepatitis C virus infection 114
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis 113
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy. 113
Prevalence of mutations and determinants of genotypic resistance to Etravirine (tmc125) in a large Italian resistance database (ARCA) 113
Totale 15.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.801
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.157 0 0 16 91 60 114 70 112 94 94 196 310
2022/20232.260 406 175 111 202 281 311 24 243 401 19 42 45
2023/2024823 68 161 45 45 70 210 29 20 21 23 30 101
2024/20253.357 41 61 357 121 72 304 251 282 166 175 481 1.046
2025/20267.373 968 554 525 805 634 347 821 213 684 700 220 902
2026/2027868 164 371 333 0 0 0 0 0 0 0 0 0
Totale 25.856